A study suggests an increase in the risk for pseudotumor cerebri syndrome with current users of fluoroquinolones. When is medical attention warranted?
This Week on NeurologyLive® — April 22, 2024
Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
Efficacy and Safety of Fremanezumab Consistent in Patients With Migraine and Obesity
Episode 88: 2023 AAN Annual Meeting Highlights
Long-Term Atogepant Effective, Safe as Migraine Preventive, Open-Label Studies Show
This Week on NeurologyLive® — April 15, 2024